Evidence map›Paper›PMID 42346299›Full record

ReviewDiseases (Basel, Switzerland)2026

The Eye and the Brain: Photonic Devices in Neuro-Ophthalmology.

Alessandro Avitabile, Marco Zeppieri, Ludovica Cannizzaro, Giuseppe Gagliano, Maria Francesca Cordeiro, Fabiana D'Esposito, Francesco Cappellani, Maria Vadalà, Vincenza Maria Elena Bonfiglio

Abstract readReview
In one paragraph

Review in Diseases (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Alessandro AvitabileBiomedicine, Neuroscience and Advance Diagnostic (BIND) Department, University of Palermo, 90128 Palermo, Italy.
Marco ZeppieriDepartment of Ophthalmology, University Hospital of Udine, 33100 Udine, Italy.ORCID 0000-0003-0999-5545
Ludovica CannizzaroBiomedicine, Neuroscience and Advance Diagnostic (BIND) Department, University of Palermo, 90128 Palermo, Italy.ORCID 0009-0001-7556-6952
Giuseppe GaglianoEye Clinic, Catania University, Policlinico G. Rodolico, 95121 Catania, Italy.ORCID 0009-0006-0059-5253
Maria Francesca CordeiroImperial College Ophthalmic Research Group (ICORG) Unit, Imperial College, 153-173 Marylebone Rd, London NW1 5QH, UK.
Fabiana D'EspositoImperial College Ophthalmic Research Group (ICORG) Unit, Imperial College, 153-173 Marylebone Rd, London NW1 5QH, UK.ORCID 0000-0002-7938-876X
Francesco CappellaniDepartment of Medicine and Surgery, University of Enna "Kore", Piazza dell'Università, 94100 Enna, Italy.ORCID 0009-0007-6807-9455
Maria VadalàBiomedicine, Neuroscience and Advance Diagnostic (BIND) Department, University of Palermo, 90128 Palermo, Italy.ORCID 0000-0002-2726-698X
Vincenza Maria Elena BonfiglioBiomedicine, Neuroscience and Advance Diagnostic (BIND) Department, University of Palermo, 90128 Palermo, Italy.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Photonic imaging technologies have profoundly transformed neuro-ophthalmic diagnostics by enabling non-invasive visualization of neurodegenerative processes at the retinal level. This review examines how advanced light-based modalities provide unprecedented insights into the structural, physiologic, and biologic relationships between the eye and brain in conditions such as optic neuritis, multiple sclerosis, and glaucoma. Optical coherence tomography has emerged as an essential tool for quantifying thinning of the retinal nerve fiber layer and ganglion cell layer, serving as reliable biomarkers of axonal loss and disease progression across multiple sclerosis subtypes and optic neuropathies. Detection of apoptosing retinal cells imaging enables real-time visualization of retinal ganglion cell apoptosis preceding irreversible structural damage, offering a critical window for early intervention in various neurodegenerative conditions, in particular, glaucoma. Two-photon microscopy with adaptive optics enables subcellular-resolution imaging of retinal neurons, microvascular dynamics, and inflammatory processes in vivo, facilitating the characterization of neurodegenerative mechanisms at unprecedented spatial scales and redefining neuro-ophthalmology by positioning the retina as an accessible extension of the central nervous system. This review critically examines how established and investigational photonic imaging modalities may support earlier disease detection, longitudinal monitoring, and biomarker development in neuro-ophthalmic and neurodegenerative disorders, with potential implications for more timely and targeted management strategies.

Indexed as

detection of apoptosing retinal cellsglaucomamultiple sclerosisneurodegenerative biomarkersneuro-ophthalmologyoptical coherence tomographyoptic neuritisphotonic imagingretinal neurodegenerationtwo-photon microscopy

Identifiers

PMID42346299
PMCPMC13298236

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.